esorubicin has been researched along with Adenocarcinoma, Basal Cell in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giuliani, FC; Goldin, A; Kaplan, NO; Zirvi, KA | 1 |
| Akman, S; Blayney, D; Doroshow, J; Leong, L; Margolin, K; McNamara, M; Morgan, R; Multhauf, P; Raschko, J; Somlo, G | 1 |
| Fleming, TR; Salmon, SE; Vaughn, CB | 1 |
| Chauffert, B; Coudert, B; Dumas, M; Martin, F; Rey, D | 1 |
| Blayney, DW; Carr, BI; Doroshow, JH; Goldberg, DA; Leong, LA | 1 |
| Chauffert, B; Hammann, A; Martin, F; Martin, M; Michel, MF | 1 |
3 trial(s) available for esorubicin and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Phase II study of 4'-deoxydoxorubicin (esorubicin) in advanced or metastatic adenocarcinoma of the stomach.
Topics: Adenocarcinoma; Adult; Aged; Doxorubicin; Drug Evaluation; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1991 |
Phase II evaluation of esorubicin (4'deoxydoxorubicin) in pancreatic adenocarcinoma: a Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pancreatic Neoplasms; Risk Factors | 1990 |
Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cells.
Topics: Adenocarcinoma; Amiodarone; Animals; Antibiotics, Antineoplastic; Cell Line; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Rats; Verapamil | 1987 |
3 other study(ies) available for esorubicin and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin.
Topics: Adenocarcinoma; Animals; Carmustine; Colonic Neoplasms; Doxorubicin; Fluorouracil; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Rectal Neoplasms; Transplantation, Heterologous | 1981 |
Phase II trial of esorubicin in advanced pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Agents; Doxorubicin; Female; Heart Diseases; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1986 |
Amiodarone-induced enhancement of doxorubicin and 4'-deoxydoxorubicin cytotoxicity to rat colon cancer cells in vitro and in vivo.
Topics: Adenocarcinoma; Amiodarone; Animals; Benzofurans; Cell Division; Cell Nucleus; Cells, Cultured; Colonic Neoplasms; Doxorubicin; Drug Synergism; In Vitro Techniques; Microscopy, Fluorescence; Rats | 1986 |